Jianwen Zhao

ERCC 1 _ 202 Is A Prognostic Biomarker in Advanced Stage Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy

Xiaobo Fan, Xiao-Li Zhu, Xiyong Wang, 2017 .

Active targeting co-delivery system based on hollow mesoporous silica nanoparticles for antitumor therapy in ovarian cancer stem-like cells

Yunlang Cai, Nan Guo, Xin Guo, 2017, Oncology reports.

Secondary nuclear targeting of mesoporous silica nano-particles for cancer-specific drug delivery based on charge inversion

Xiaobo Fan, Xiyong Wang, Guoqiu Wu, 2016, Oncotarget.